• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有卵巢早衰的女性压力性尿失禁的患病率。

Prevalence of Stress Urinary Incontinence in Women with Premature Ovarian Insufficiency.

机构信息

State Key Laboratory of Reproductive Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Nanjing Medical University/Jiangsu Province Hospital, Nanjing Medical University, Nanjing, China.

出版信息

J Womens Health (Larchmt). 2018 Dec;27(12):1508-1512. doi: 10.1089/jwh.2018.6935. Epub 2018 Nov 28.

DOI:10.1089/jwh.2018.6935
PMID:30484729
Abstract

To determine the prevalence of stress urinary incontinence (SUI) and associated factors in women with premature ovarian insufficiency (POI). The study included 149 patients with POI and 303 control women without POI. Age, body mass index (BMI), gestational history, time since onset of POI, and status of hormone therapy (HT) for POI were recorded. There was no statistical difference in the mean age, BMI, and parity between the two groups. The prevalence of SUI in the POI group tended to be higher than that in the control group (20.9%, 30/149 vs. 16.2%, 49/303), although not significantly ( = 0.297). About 41.6% (62/149) of patients with POI received HT. Patients with POI and SUI were older ( = 0.018) and had higher BMI ( = 0.007) than women with POI without SUI ( = 0.007). Compared to nulliparas, primiparas were more likely to have SUI ( = 0.046). However, SUI developed irrespective of time since onset of oligomenorrhea/amenorrhea or HT use. Furthermore, regression analysis showed that the prevalence of SUI was higher in women 30-39 years of age (odds ratio [OR] = 3.27,  = 0.002) and older than 40 years (OR = 7.78,  = 0.001). Primiparas (OR = 2.89,  = 0.001) and vaginal delivery (OR = 2.58,  = 0.023) were associated with SUI. The prevalence of SUI was fairly high among patients with POI, and age, parity, and vaginal delivery were the main risk factors. However, duration of POI and HT use had no effect on SUI. Increasing awareness of the importance of urinary system health in this population will improve the quality of life for these women.

摘要

目的

确定早发性卵巢功能不全(POI)女性压力性尿失禁(SUI)的患病率及相关因素。

方法

本研究纳入了 149 例 POI 患者和 303 例非 POI 对照女性。记录年龄、体重指数(BMI)、妊娠史、POI 发病时间和 POI 激素治疗(HT)状态。两组间的平均年龄、BMI 和产次无统计学差异。POI 组的 SUI 患病率似乎高于对照组(20.9%,30/149 比 16.2%,49/303),但无统计学意义( = 0.297)。约 41.6%(62/149)的 POI 患者接受了 HT。POI 和 SUI 患者的年龄较大( = 0.018),BMI 较高( = 0.007),与无 SUI 的 POI 患者相比( = 0.007)。与经产妇相比,初产妇更易发生 SUI( = 0.046)。然而,SUI 的发生与月经稀发/闭经时间或 HT 使用无关。此外,回归分析显示,30-39 岁女性(比值比 [OR] = 3.27,  = 0.002)和年龄大于 40 岁的女性(OR = 7.78,  = 0.001)SUI 患病率较高。初产妇(OR = 2.89,  = 0.001)和阴道分娩(OR = 2.58,  = 0.023)与 SUI 相关。POI 患者的 SUI 患病率相当高,年龄、产次和阴道分娩是主要危险因素。然而,POI 发病时间和 HT 使用对 SUI 无影响。提高对该人群泌尿系统健康重要性的认识将提高这些女性的生活质量。

相似文献

1
Prevalence of Stress Urinary Incontinence in Women with Premature Ovarian Insufficiency.患有卵巢早衰的女性压力性尿失禁的患病率。
J Womens Health (Larchmt). 2018 Dec;27(12):1508-1512. doi: 10.1089/jwh.2018.6935. Epub 2018 Nov 28.
2
Persistent stress urinary incontinence during pregnancy and one year after delivery; its prevalence, risk factors and impact on quality of life in Taiwanese women: An observational cohort study.孕期及产后一年持续性压力性尿失禁;其在台湾女性中的患病率、危险因素及对生活质量的影响:一项观察性队列研究
Taiwan J Obstet Gynecol. 2018 Jun;57(3):340-345. doi: 10.1016/j.tjog.2018.04.003.
3
The epidemiological study of women with urinary incontinence and risk factors for stress urinary incontinence in China.中国女性尿失禁的流行病学研究及压力性尿失禁的危险因素
Menopause. 2009 Jul-Aug;16(4):831-6. doi: 10.1097/gme.0b013e3181967b5d.
4
Stress urinary incontinence six months after first vaginal delivery.初产妇产后 6 个月压力性尿失禁。
Eur J Obstet Gynecol Reprod Biol. 2010 Jun;150(2):210-4. doi: 10.1016/j.ejogrb.2010.02.039. Epub 2010 Mar 12.
5
Autoimmune polyglandular syndrome type 3 (APS-3) among patients with premature ovarian insufficiency (POI).卵巢早衰(POI)患者中的自身免疫性多腺体综合征3型(APS-3)。
Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:61-5. doi: 10.1016/j.ejogrb.2016.05.023. Epub 2016 May 20.
6
Risk factors of postpartum stress urinary incontinence in primiparas: What should we care.初产妇产后压力性尿失禁的危险因素:我们应该关注什么。
Medicine (Baltimore). 2021 May 21;100(20):e25796. doi: 10.1097/MD.0000000000025796.
7
Descriptive cross sectional study on prevalence, perceptions, predisposing factors and health seeking behaviour of women with stress urinary incontinence.描述性横断面研究:压力性尿失禁女性的患病率、认知、易患因素和求医行为。
BMC Womens Health. 2014 Jul 2;14:78. doi: 10.1186/1472-6874-14-78.
8
Relationship of urodynamic parameters and obesity in women with stress urinary incontinence.压力性尿失禁女性患者尿动力学参数与肥胖的关系
J Reprod Med. 2002 Jul;47(7):559-63.
9
Pelvic floor disorders in women with premature ovarian insufficiency: a cross-sectional study.女性早发性卵巢功能不全患者的盆底功能障碍:一项横断面研究。
Menopause. 2020 Apr;27(4):450-458. doi: 10.1097/GME.0000000000001523.
10
Establishment and validation of a simple nomogram for predicting early postpartum stress urinary incontinence among women with vaginal delivery: a retrospective study.建立并验证一个简单的列线图模型以预测阴道分娩后妇女的早期产后压力性尿失禁:一项回顾性研究。
BMC Womens Health. 2023 Jan 9;23(1):8. doi: 10.1186/s12905-023-02160-2.

引用本文的文献

1
Cell Therapy in the Treatment of Female Stress Urinary Incontinence: Current Status and Future Proposals.细胞疗法治疗女性压力性尿失禁:现状与未来建议
Life (Basel). 2024 Jul 10;14(7):861. doi: 10.3390/life14070861.
2
Advances in the molecular pathogenesis and cell therapy of stress urinary incontinence.压力性尿失禁的分子发病机制与细胞治疗进展
Front Cell Dev Biol. 2023 Feb 8;11:1090386. doi: 10.3389/fcell.2023.1090386. eCollection 2023.